Literature DB >> 17550935

Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement.

Mario Malerba1, Alessandro Radaeli, Beatrice Ragnoli, Paolo Airo', Massimo Corradi, Antonio Ponticiello, Alberto Zambruni, Vittorio Grassi.   

Abstract

BACKGROUND: Systemic sclerosis (SSc) is a connective tissue disorder of unknown etiology that is often complicated by pulmonary involvement, with pulmonary hypertension (PH) and interstitial lung disease (ILD) being the major causes of death. It has been suggested that the amount of nitric oxide (NO) in exhaled air may predict the onset of complications. The aim of the study was to measure exhaled NO in SSc patients and investigate its relationship with pulmonary involvement with and without PH.
METHODS: Fifty patients (5 men and 45 women; mean age, 59.1 +/- 11.7 years [+/- SD]) with a diagnosis of SSc based on the preliminary criteria of the American Rheumatism Association, and 40 healthy control subjects (5 men and 35 women; mean age, 58.3 +/- 12.2 years) underwent exhaled NO measurements by means of a chemiluminescence analyzer, pulmonary function tests, high-resolution thorax CT, and Doppler echocardiography.
RESULTS: Exhaled NO concentrations were significantly higher in SSc patients than control subjects (p = 0.02), and significantly lower in the patients with ILD and/or PH than in those without PH (p < 0.01). There was a significant inverse correlation between pulmonary artery systolic pressure and exhaled NO concentration in all of the studied patients (r = - 0.5, p < 0.001).
CONCLUSIONS: Our results indicate that exhaled air NO concentrations are lower in SSc patients with lung involvement than in those without, and that SSc patients without ILD or PH have higher exhaled NO values than healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17550935     DOI: 10.1378/chest.06-2929

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosis.

Authors:  Zeling Cao; Stephen C Mathai; Laura K Hummers; Ami A Shah; Fredrick M Wigley; Noah Lechtzin; Paul M Hassoun; Reda E Girgis
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

2.  Fractional Exhaled Nitric Oxide Measurement in Pulmonary Hypertension: A Follow-Up Study.

Authors:  Nilay Orak Akbay; Zuleyha Bingol; Esen Kiyan; Ekrem Bilal Karaayvaz; Ahmet Kaya Bilge; Halim Issever; Gulfer Okumus
Journal:  Clin Appl Thromb Hemost       Date:  2017-04-10       Impact factor: 2.389

3.  Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques.

Authors:  Pravin B Sehgal; Somshuvra Mukhopadhyay; Kirit Patel; Fang Xu; Sharilyn Almodóvar; Rubin M Tuder; Sonia C Flores
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-31       Impact factor: 5.464

4.  Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging.

Authors:  Jason Lee; Reuben Reich; Fang Xu; Pravin B Sehgal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-31       Impact factor: 5.464

Review 5.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

Review 6.  Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited.

Authors:  Armando Gabrielli; Silvia Svegliati; Gianluca Moroncini; Giovanni Pomponio; Mariarosaria Santillo; Enrico V Avvedimento
Journal:  Semin Immunopathol       Date:  2008-06-12       Impact factor: 11.759

Review 7.  Exhaled nitric oxide as a biomarker in COPD and related comorbidities.

Authors:  Mario Malerba; Alessandro Radaeli; Alessia Olivini; Giovanni Damiani; Beatrice Ragnoli; Paolo Montuschi; Fabio L M Ricciardolo
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411

Review 8.  Clinical application of exhaled nitric oxide measurements in a korean population.

Authors:  Woo-Jung Song; Ji-Won Kwon; Eun-Jin Kim; Sang-Min Lee; Sae-Hoon Kim; So-Yeon Lee; Sang-Heon Kim; Heung-Woo Park; Yoon-Seok Chang; Woo Kyung Kim; Jung Yeon Shim; Ju-Hee Seo; Byoung-Ju Kim; Hyo Bin Kim; Dae Jin Song; Gwang Cheon Jang; An-Soo Jang; Jung-Won Park; Ho-Joo Yoon; Joo-Shil Lee; Sang-Heon Cho; Soo-Jong Hong
Journal:  Allergy Asthma Immunol Res       Date:  2014-08-19       Impact factor: 5.764

9.  Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

Authors:  Natalie K Kozij; John T Granton; Philip E Silkoff; John Thenganatt; Shobha Chakravorty; Sindhu R Johnson
Journal:  Can Respir J       Date:  2017-02-14       Impact factor: 2.409

10.  Application of nitric oxide measurements in clinical conditions beyond asthma.

Authors:  Andrei Malinovschi; Dora Ludviksdottir; Ellen Tufvesson; Giovanni Rolla; Leif Bjermer; Kjell Alving; Zuzana Diamant
Journal:  Eur Clin Respir J       Date:  2015-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.